Programme

MIBio 2022 Programme

08:00 Registration opens

09:00 Opening remarks

09:15 Title TBC
Paul Varley | VP CMC Development, Alchemab Therapeutics Ltd.

09:45 Title TBC
Shahid Uddin | Director of Drug Product, Formulation & Stability, Immunocore

10:15 Morning Coffee

11:00 Title TBC
Yuval Elani – Asst. Professor & UKRI Future Leaders Fellow, Imperial College

11:30Title TBC
Luca Badiali | Group Leader, Kymab Ltd.

12:00 Lunch Break, Exhibition and Posters

13:15 Introduction to the afternoon session

13:30 Title TBC
Sara Pereira | Senior Scientist, AstraZeneca

14:00 Discussion Panel

15:00 Exhibitors highlights

15:30 Coffee break, Exhibition and Posters

16:00 Title TBC
Söhnke Voss | Business Development Manager, EMEA, Avanti Polar Lipids

16:30 Title TBC
Farnaz Esmaeili | Project Manager, Regulatory Affairs, Cell and Genetherapy, GSK

17:00 Concluding remarks

17:10 Conference ends